[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@Pharmdca Pharmdca

Several biotech stocks are gaining attention, including $vktx, $mdgl, and $srpt, which are showing strength despite market volatility. $vktx, in particular, has been a focus, with some investors expressing confidence in its obesity treatment and dismissing misinformation that led to a post-data stock drop. Meanwhile, $bmnr and $coin are also being discussed as having potential for growth, with some investors long on these names.

Engagements: XXXXXX #

X Week XXXXXXX +82%
X Month XXXXXXXXX -XX%
X Months XXXXXXXXXX +18%
X Year XXXXXXXXXX -XX%

Mentions: XX #

X Week XX -XX%
X Month XXX -XX%
X Months XXXXX +32%
X Year XXXXX -XX%

Followers: XXXXXXX #

X Week XXXXXXX +0.12%
X Month XXXXXXX -XXXX%
X Months XXXXXXX -XX%
X Year XXXXXXX +4.30%

CreatorRank: XXXXXXX #

Social Influence

Social category influence stocks XXXX% finance XXXXX% cryptocurrencies #4648 technology brands XXXX% exchanges #1779 fashion brands XXXX% travel destinations XXXX% automotive brands XXXX% social networks XXXX%

Social topic influence $vktx #8, $gpcr #7, $lly #15, $zs #6, $guts #1, acquisition #658, target 3.19%, market cap #370, $nvo #87, $odd #12

Top accounts mentioned or mentioned by @pgainz96934 @fat_pockets123 @troutandchar @biopharmiq @william_r2rclub @willbestonks @dragonmaxgoku @omillionaires @rick82464 @savoryseaw50174 @andre_agtc @xairsman @fwcweather @secgov @scorpionfund @veganhippo21 @stephanklingel1 @wallstsai @zhongxingzhang @agarwoodcapital

Top Social Posts

Top posts by engagements in the last XX hours

"New position in $ODD 52+"
X Link 2025-10-09T16:04Z 108.1K followers, 6474 engagements

"Remember Big Pharma had made huge blunders in the past highlighting lessons in overpaying for unproven assets or ignoring market realities Heres a list of some of the big buyout blunders by Big pharma Pfizer acquired GBT for $XXX billion in 2022. Failed Gileads Acquisition of Kite Pharma (2017 $XXXX billion) Sanofis Acquisition of Bioverativ (2018 $XXXX billion) AbbVies Acquisition of Stemcentrx (2016 $XXXX billion $Amgen/Onyx Deal size:$10.4 billion 2013 XXXX billion is an awful lot to pay for a company whose star product has brought in a combined $XXXX billion through its first six years of"
X Link 2025-11-06T00:41Z 108.1K followers, 11.2K engagements

"$DAWN Bullish momentum post recent earnings release. Stock has been in a long downward trend and stuck around $X for quite some time. Nice to see stock broke that bearish trend and slowly making higher highs"
X Link 2025-11-11T18:48Z 108.1K followers, 11.7K engagements

"$CELC Closed full position in 90s from mid 30s Moving cash to where I see dip opportunities"
X Link 2025-11-20T18:00Z 108.1K followers, 4774 engagements

"$CELC almost hit my target 🎯 triple digits. Reason I closed my full position Another big winner this year"
X Link 2025-11-20T18:23Z 108.1K followers, 6014 engagements

"$ZS added 263's"
X Link 2025-11-26T14:38Z 108.1K followers, 4055 engagements

"$ZS June gap filled. Nice pullback"
X Link 2025-11-26T15:08Z 108.1K followers, 4063 engagements

"$ZS got a good starting position today on dips. Love such pullback opportunities over and over again in different equities"
X Link 2025-11-26T16:18Z 108.1K followers, 3597 engagements

"Positions part X $DAWN $CRVS $TGTX $LRMR $IVVD $RZLT $PEPG $TECX $LULU $PDSB $TRVI $SLDB $IOVA $MREO $MDNAF"
X Link 2025-11-26T17:42Z 108.1K followers, 3975 engagements

"$ZS BTD for me $ZS CapitalOne upgraded Zscaler from Equal-Weight to Overweight and raised the price target to $XXX from $289"
X Link 2025-11-26T19:14Z 108.1K followers, 6304 engagements

"Added small $ZS $244+"
X Link 2025-12-02T15:04Z 108.1K followers, 3614 engagements

"Bitcoin reclaimed 90K $COIN"
X Link 2025-12-02T15:14Z 108.1K followers, 4503 engagements

"$GUTS New speculative position $XXXX into 2026 with top line pivotal data from REMAIN-1 Pivotal Cohort Q2 and potential PMA submission in the second half of 2026"
X Link 2025-12-03T16:45Z 108.1K followers, 4947 engagements

"$VKTX FDA meeting this month. A direct entry to PH3 for the oral drug will be huge for this small cap biotech company pushing into obesity space against $LLY Short term catalyst"
X Link 2025-12-04T15:34Z 108.1K followers, 18.5K engagements

"$VKTX up XX% and $LLY down 2%. If any BP makes a move on $VKTX I expect $LLY shares to have short term pullback and an acquirer company stock price would react positively. Irrespective of an acquisition or not holding both $VKTX $LLY long term. $GUTS new position yesterday a different approach to Obesity for maintaining weight loss once GLP's are discontinued. Market cap is small and next data a randomized trial in Q2 will definitely be a real validation for if this approach works overtime"
X Link 2025-12-04T17:20Z 108.1K followers, 9291 engagements

"$PRAX up huge on Pre-NDA Meeting with FDA Advancing Towards First NDA Submission earlier than expected $VKTX FDA meeting this month for their oral drug for obesity I cant stress enough how big it will be if granted ph3 green light which will significantly reduce time to market"
X Link 2025-12-04T22:22Z 108.1K followers, 34.3K engagements

"#Biotechs $XBI as 2025 year is winding down theres no doubt that 2025 turned out to be a good year for small cap biotech companies. This is not based on the Index performance but how selective good companies have outperformed. Best way to play biotech sector is BTD post data when companies stocks are de-risked. Holding through binary events often turned out to be a nightmare for investors"
X Link 2025-12-08T01:10Z 108.1K followers, 7554 engagements

"$GPCR now green to red. Stock all over the place. Need to see the safety profile and there's no mention of it in the PR. Efficacy on the other hand is really good"
X Link 2025-12-08T13:11Z 108.1K followers, 6665 engagements

"$GPCR added some shares 50's post presentation. Now own $VKTX $LLY $GPCR $GUTS for my obesity basket"
X Link 2025-12-08T15:04Z 108.1K followers, 5749 engagements

"$VKTX data is from XX weeks and showed 10-11% placebo adjusted weight loss at the highest dose in just XX weeks and no drug plateauing outpacing Orforglipron $LLY drug which showed weight loss of XXX% (placebo adjusted) at the highest dose and that in XX weeks. Faster titration led to higher GI issues. Going forward management planning to use X weeks titration vs X weeks $GPCR X week titration as well"
X Link 2025-12-08T15:11Z 108.1K followers, 9911 engagements

"@WillBeStonks and be selective"
X Link 2025-12-08T15:35Z 108.1K followers, XXX engagements

"@DragonMaxGoku Efficacy is good and being a small molecule- That hype but other than that I agree with you"
X Link 2025-12-09T22:27Z 108.1K followers, XXX engagements

"$ODD stock is trying to make a bottom here. Stock at its previous big support here around $XX. Long $ODD"
X Link 2025-10-17T14:03Z 108.1K followers, 5782 engagements

"$VKTX just a reminder for those folks who only pay attention to the stock price and presents their bearish opinions based on the price action because. These are impatient people. A reminder- $MDGL 5-year chart showed huge price fluctuations but in the end is one of my best portfolios wins lately. Rome is not built in a day"
X Link 2025-11-25T17:08Z 108.1K followers, 16.2K engagements

"$ZS picked Jan 2027 strike $XXX calls and shares"
X Link 2025-11-26T16:19Z 108.1K followers, 3364 engagements

"LT position updates: Part X # XX Portfolio Pick Buyouts $RNA $NARI $BPMC $MYOV $IMGN $KRTX $HZNP $PRVB $ISEE $BLU $CTIC $FSTX $ICVX $LVGO $STML $JUNO $CMRX $RLYP $ITCI $KVUE Tech positions- $AMZN $TSLA $SOFI $COIN $AMD $GOOG $NVDA $TTD $IREN $NBIS $HOOD $META $ZS $UBER $RDDT $PYPL Bio positions: $VKTX $TMDX $MDGL $CYTK $QURE $BBIO $SRPT $AXSM $LLY $OCUL $OSCR $UNH $HROW $SLNO"
X Link 2025-11-26T17:42Z 108.1K followers, 23.2K engagements

"$NVO only way they can catch up with $LLY is acquiring $VKTX that is already in PH3 and Oral could get the green light to move directly into ph3 trials. Plus they get PH3 drug ready for MASH. However question is how much Viking is looking to sell their company for"
X Link 2025-12-03T19:40Z 108.1K followers, 34.6K engagements

"$SNOW starter position $230's"
X Link 2025-12-04T15:23Z 108.1K followers, 5105 engagements

"$GPCR why no full PR with safety analysis Maybe we see during the conference call. Please don't try to copy $NVO $AMGN with partial PR's Let's wait for the conference call updates"
X Link 2025-12-08T13:19Z 108.1K followers, 10.7K engagements

"$GPCR this is my concern with safety. $PFE had similar incidence and end up shutting down their program later. Incidence of this during a larger phase X trial"
X Link 2025-12-08T14:06Z 108.1K followers, 8710 engagements

"$NFLX a buy here"
X Link 2025-12-08T14:43Z 108.1K followers, 7613 engagements

"Biotech winners post data- good day for biotech sector $GPCR up XXX% $KYMR almost XX% $FULC almost XX% $WVE 89%"
X Link 2025-12-08T15:02Z 108.1K followers, 28.7K engagements

"Why it is important to buy post data when you get a sense of how data is $GPCR $XX BOOM $VKTX will shine. Patience"
X Link 2025-12-08T15:13Z 108.1K followers, 8039 engagements

"$CRVS reports data in January would be awesome with positive news around JPM conference. Atopic dermatitis-extension cohort X of the Phase X clinical trial $KYMR up huge on AD news"
X Link 2025-12-08T15:34Z 108.1K followers, 6235 engagements

"$NVO with failed acquisition of MTSR I believe they will make another bold move to hunt for Obesity acquisition $VKTX or $GPCR Surprise good data from $GPCR this morning and market cap not much expensive considering MTSR recent acquisition $VKTX my bold prediction- It will crush $LLY weight loss numbers and better safety with 4-week titration in a much larger trial going forward. Viking already reported better weight loss in just XX weeks and expect even better results in the future. Stay tuned"
X Link 2025-12-08T19:39Z 108.1K followers, 23.8K engagements

"$OCUL clean break out and XX week highs post company announcement that company plans to accelerate AXPAXLI wet AMD NDA opting for the 505(b)(2) pathway and targeting submission shortly after positive SOL-1 Year X data (on track for Q1 2026)"
X Link 2025-12-08T19:50Z 108.1K followers, 5207 engagements

"$TERN Hitting All-time highs. Stock was struggling around $X for long. Now halted Another big turnaround in the small cap biotech sector. Terns Pharmaceuticals announced updated Phase X TERN-701 data presented today at ASH showing XX% MMR at XX weeks (75% at 320mg) with favorable safety; investor call at 4:30pm ET today"
X Link 2025-12-08T20:15Z 108.1K followers, 6932 engagements

"$GPCR offering in hindsight. Significant cash raised Stock heading higher Still $VKTX remains my top position in the obesity space besides $LLY $GUTS & $GPCR are new positions since market cap still cheap as this sector remains hot going forward $GUTS could have significant upside from here if data continues to show durability when they report data early next year"
X Link 2025-12-08T22:56Z 108.1K followers, 7958 engagements

"$MTSR acquisition sets the floor for next targets to be acquired in the obesity sector. $XX Billion acquisition for one drug should put $VKTX & $GPCR on the table and both can easily double up from here. Both trades around $X Billion cap and cheap"
X Link 2025-12-09T15:19Z 108.1K followers, 10.4K engagements

"$LUCD good product good data but management not shareholder friendly. Stock should have doubled in this biotech friendly environment but too many cash raises is a concern I haven't seen another management doing so many secondaries"
X Link 2025-12-09T15:34Z 108.1K followers, 7143 engagements

"$AMZN Amazon on Wednesday committed to investing over $XX billion in Indias cloud and artificial intelligence space by 2030 as hyperscalers race to get a foothold in the market"
X Link 2025-12-10T05:59Z 108.1K followers, 5357 engagements

"$TERN stock up roughly XXX% from early November. Despite obesity shutting down stock went parabolic from $X to $XX after reporting unprecedented Phase X CML efficacy data with XX% MMR achievement by XX weeks in a refractory patient population"
X Link 2025-12-10T16:31Z 108.1K followers, 5697 engagements

"$GUTS Next target $XXX chart is ready for breakout above $XXX area. Company reporting X year data in Q2 2026 for Revita a procedure designed to complement GLP-1 drugs for obesity but not competing against. Conservative market penetration represents $1B annual revenue potential if successful X year data in Q2 2026 will be an important milestone for the company to show how durable these results are post GLP-1 discontinuations. If Revita procedure shows weight loss post GLP-1 discontinuation expect shares to move significantly higher. I'm long $GUTS from $1.8+"
X Link 2025-12-10T17:12Z 108.1K followers, 13.6K engagements

"$LLY High discontinuation rates Diarrhea rates high"
X Link 2025-12-11T12:12Z 108.1K followers, 7789 engagements

"$CRBP Three adverse events of mild anxiety and one of mild irritability were reported in the obese MAD cohort at XXX mg/day. Will be tough for drug to go through FDA if future trials (large N) shows even more adverse effects in the future"
X Link 2025-12-11T12:19Z 108.1K followers, 4251 engagements

"Equities since opening bell $SPY $QQQ"
X Link 2025-12-11T15:59Z 108.1K followers, 4173 engagements